Skip Navigation

Journal of Intellectual Property Law & Practice 2008 3(8):489; doi:10.1093/jiplp/jpn123
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors (2008). Published by Oxford University Press. All rights reserved

Current Intelligence

Current Intelligence

The first 10% of the full text of this article appears below.


   Current Intelligence – by subject
 
Patents
Clinical trial not a patent infringement, having an ‘indirect’ business purpose (Sankyo Co., Ltd & Shanghai Sankyo Pharmaceutical Co., Ltd v Beijing Wansheng Drug Industry Co., Ltd (2006) Erzhongminchuzi No.: 04134; Eli Lilly Company v Ganli Drug Industry Co., . . . [Full Text of this Article]

Trade marks
Copyright

   Current Intelligence – by jurisdiction
 
China
Germany
UK
US

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?